Literature DB >> 2472117

Disulfide structures of human interleukin-6 are similar to those of human granulocyte colony stimulating factor.

C L Clogston1, T C Boone, B C Crandall, E A Mendiaz, H S Lu.   

Abstract

The amino acid sequences of human interleukin-6 and granulocyte colony stimulating factor are approximately 30% homologous in the N-terminal region. The relative positions of four half-cystines in human interleukin-6 (IL-6) match four of the five in human granulocyte colony stimulating factor. Labeling experiments of recombinant interleukin-6 with tritiated iodoacetate confirmed that the molecule forms two intramolecular disulfide bonds and contains no detectable level of free sulfhydryls. By isolation and characterization of tryptic and subtilytic peptides obtained from different proteolytic digestions, the disulfide bonds of the IL-6 molecule were assigned to Cys44-Cys50 and Cys73-Cys83. The two disulfide bridges form two small loops which are separated by 22 amino acids. These structures are similar to those of recombinant granulocyte colony stimulating factor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2472117     DOI: 10.1016/0003-9861(89)90205-1

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  10 in total

Review 1.  Interleukin-6: structure-function relationships.

Authors:  R J Simpson; A Hammacher; D K Smith; J M Matthews; L D Ward
Journal:  Protein Sci       Date:  1997-05       Impact factor: 6.725

2.  Characterization, promoter analysis and expression of the interleukin-6 gene in blunt snout bream, Megalobrama amblycephala.

Authors:  Xiaoqin Fu; Zhujin Ding; Jun Fan; Huanling Wang; Fengjuan Zhou; Lei Cui; Chen Boxiang; Weimin Wang; Hong Liu
Journal:  Fish Physiol Biochem       Date:  2016-05-28       Impact factor: 2.794

3.  Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6.

Authors:  T M Rose; A G Bruce
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

4.  Human herpesvirus 8 interleukin-6 (vIL-6) signals through gp130 but has structural and receptor-binding properties distinct from those of human IL-6.

Authors:  X Wan; H Wang; J Nicholas
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

5.  Complete 1H, 15N and 13C assignments, secondary structure, and topology of recombinant human interleukin-6.

Authors:  G Y Xu; J Hong; T McDonagh; M Stahl; L E Kay; J Seehra; D A Cumming
Journal:  J Biomol NMR       Date:  1996-09       Impact factor: 2.835

6.  Recombinant human IL-6 expressed in E. coli undergoes selective N-terminal degradation: evidence that the protein consists of a stable core and a nonessential flexible N-terminal.

Authors:  A E Proudfoot; S C Brown; A R Bernard; J Y Bonnefoy; E H Kawashima
Journal:  J Protein Chem       Date:  1993-08

7.  The glutathione peroxidase 8 (GPX8)/IL-6/STAT3 axis is essential in maintaining an aggressive breast cancer phenotype.

Authors:  Anees Khatib; Balakrishnan Solaimuthu; Michal Ben Yosef; Areej Abu Rmaileh; Mayur Tanna; Gidi Oren; Michal Schlesinger Frisch; Jonathan H Axelrod; Michal Lichtenstein; Yoav D Shaul
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-18       Impact factor: 11.205

8.  Structure-function analysis of human IL-6: identification of two distinct regions that are important for receptor binding.

Authors:  A Hammacher; L D Ward; J Weinstock; H Treutlein; K Yasukawa; R J Simpson
Journal:  Protein Sci       Date:  1994-12       Impact factor: 6.725

9.  Improved detection of biomarkers in cervico-vaginal mucus (CVM) from postpartum cattle.

Authors:  Mounir Adnane; Paul Kelly; Aspinas Chapwanya; Kieran G Meade; Cliona O'Farrelly
Journal:  BMC Vet Res       Date:  2018-09-29       Impact factor: 2.741

Review 10.  Hidden Relationships between N-Glycosylation and Disulfide Bonds in Individual Proteins.

Authors:  Tania Bakshi; David Pham; Raminderjeet Kaur; Bingyun Sun
Journal:  Int J Mol Sci       Date:  2022-03-29       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.